BOLT:NASDAQ, Bolt Biotherapeutics, Inc.

BOLT stock overview

Bolt Biotherapeutics, Inc. (BOLT:NASDAQ) closed at $4.91 on November 20, 2026, down 2.96% on the day. The stock trades 36.9% below its 52-week high of $7.78 and 58.4% above its 52-week low of $3.10. Over the past year, it gained 3.6%. Bolt Biotherapeutics, Inc. is part of the Health Care sector.

Key figures

Price
$4.91
Day change
-2.96%
Volume
60,465
Average volume
257,496
Market cap
12M+
52-week range
$3.10 – $7.78
50-day average
$4.75
200-day average
$4.49

Price action over the past year

In 252 trading sessions since November 20, 2025, BOLT closed higher on 120 days (48%). Its best day was October 23, 2026 (+49.64%) and its worst was August 12, 2026 (-13.32%). The stock moved 10% or more in a single session 9 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

BOLT news

About Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.

Similar stocks

Find more stocks like BOLT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.